Tag Archives: Pimavanserin

Management of BPSD in Alzheimer’s Disease (International Psychogeriatrics)

Summary A recent review examines current and emerging treatments for Behavioural and Psychological Symptoms of Dementia (BPSD) in Alzheimer’s Disease. This research was first aired at the 2015 International Psychogeriatric Association Meeting. The consensus view is that non-pharmacological approaches are … Continue reading

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Pimavanserin for Patients with Parkinson’s Disease Psychosis (NHS Choices / Lancet)

Summary Parkinson’s Disease psychosis is a common side-effect in Parkinson’s Disease patients, involving hallucinations and delusions (irrational beliefs). Roughly a half of people with Parkinson’s disease may show psychotic symptoms eventually. Recent research assessed safety and efficacy of a new … Continue reading

Posted in Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, NHS Digital (Previously NHS Choices), Parkinson's Disease, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Treatment of Visual Hallucinations in Neurodegenerative Diseases (Future Neurology)

Summary Treatment of visual hallucinations in neurodegenerative disorders is at an early stage of development due to the underlying mechanisms being imperfectly understood. The authors consider various potential approaches to developing treatments, but caution readers that any single treatment is … Continue reading

Posted in Acute Hospitals, Antipsychotics, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Management of Condition, Mental Health, Models of Dementia Care, NHS, Non-Pharmacological Treatments, Patient Care Pathway, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment